AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...

Life’s origin story just became even more mysterious. Using mathematics and information theory, Robert G. Endres of Imperial College London found that the spontaneous emergence of life from nonliving ...

Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, ...

Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...

180 Life Sciences Corp (NASDAQ:ATNF) shares are soaring Tuesday after the company provided an update on its Ethereum (CRYPTO: ETH) treasury strategy. What Happened: At the end of July, 180 Life ...

Texas’s premier life science conference returns to Houston in November, spotlighting breakthrough innovations in therapeutics, medical technology, and digital health. HOUSTON--(BUSINESS WIRE)--Rice ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...

Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...

Caris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, David Dean ...

Irving-based Caris Life Sciences has opened a new $45 million liquid biopsy laboratory in Phoenix. The lab enables the company to further develop and launch its blood-based cancer test called Caris ...

On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq’s opening bell in New York, marking the company’s awaited initial public offering. Founded in 2008 by David ...